Get the Stockscreener App
0.7677
5.64%
0.041
Coherus Oncology Inc Stock (CHRS) Forecast
The Coherus Oncology Inc (CHRS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.2253, representing a +580.65% increase from the current price of $0.7677. The highest analyst price target is $7.2496, and the lowest is $3.2011.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CHRS Price Target
Average 7.3654
(+859.41% Upside)
Is Coherus Oncology Inc (CHRS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.25 | Neutral |
| STOCH(9,6) | 25.24 | Neutral |
| STOCHRSI(14) | 12.55 | Buy |
| MACD(12,26) | -0.0285 | Buy |
| ADX(14) | 15.18 | Neutral |
| William %R | -82.53 | Buy |
| CCI(14) | -91.55 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7955
Sell
|
0.7834
Sell
|
| MA20 |
0.7882
Sell
|
0.8025
Sell
|
| MA50 |
0.8844
Sell
|
0.8654
Sell
|
| MA100 |
0.9585
Sell
|
0.9585
Sell
|
| MA200 |
1.0694
Sell
|
1.1733
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CHRS could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CHRS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.25 indicates that CHRS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.24 indicates that CHRS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.55 indicates that CHRS is oversold. This suggests that CHRS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.18 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -91.55 indicates that CHRS is still oversold but not to an extreme extent.
Long-term CHRS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Coherus Oncology Inc financial reports and earnings history, Coherus Oncology Inc (CHRS) stock could reach $11.96 by 2030, $6.5426 by 2040 and $27.01 by 2050. See the projected annual prices until 2050 of the Coherus Oncology Inc stock below:
- Coherus Oncology Inc (CHRS) is expected to reach an average price of $4.1309 in 2035, with a high prediction of $4.1324 and a low estimate of $3.3153. This indicates an $438.09% rise from the last recorded price of $0.7677.
- Coherus Oncology Inc (CHRS) stock is projected to chart a bullish course in 2040, with an average price target of $6.721, representing an $775.47% surge from its current level. The forecast ranges from a conservative $6.3082 to a sky-high $6.5426.
- Our analysts predict Coherus Oncology Inc (CHRS) to jump 1,968% by 2045, soaring from $15.65 to an average price of $15.88, potentially reaching $14.96. While $15.65 is the low estimate, the potential upside is significant.
- Coherus Oncology Inc (CHRS) stock is expected to climb by 2050, reaching an average of $25.03, a $3,161% jump from its current level. However, a wide range of estimates exists, with high and low targets of $27.01 and $26.38, respectively, highlighting the market's uncertainty.
Coherus Oncology Inc Stock (CHRS) Year by Year Forecast
Coherus Oncology Inc Stock (CHRS) Price Forecast for 2025
Coherus Oncology Inc Stock (CHRS) is expected to reach an average price of $4.9515 in 2025, with a high prediction of $9.8279 and a low estimate of $0.0751. This indicates an +544.98% rise from the last recorded price of $0.7677.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $4.9268 | $3.2011 | $7.2496 | +541.76% |
| August, 2025 | $5.7797 | $4.4125 | $6.5697 | +652.86% |
| September, 2025 | $7.6627 | $4.9255 | $8.7627 | +898.13% |
| October, 2025 | $6.6913 | $5.9713 | $8.404 | +771.61% |
| November, 2025 | $6.7642 | $6.067 | $8.4628 | +781.10% |
| December, 2025 | $5.3429 | $4.8872 | $7.6314 | +595.96% |
Coherus Oncology Inc Stock (CHRS) Price Forecast for 2026
The predicted value for Coherus Oncology Inc (CHRS) in 2026 is set at an average of $7.1895. Estimates vary from a peak of $11.53 to a trough of $2.8493, indicating an +836.50% surge from the present price of $0.7677.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.4758 | $5.1586 | $7.7558 | +873.79% |
| February, 2026 | $6.4787 | $6.1987 | $8.103 | +743.92% |
| March, 2026 | $6.9467 | $5.6845 | $7.6017 | +804.87% |
| April, 2026 | $6.7203 | $6.1853 | $11.53 | +775.38% |
| May, 2026 | $5.0733 | $4.3118 | $6.7561 | +560.84% |
| June, 2026 | $3.7662 | $3.5162 | $5.709 | +390.58% |
| July, 2026 | $5.1748 | $3.3919 | $5.4691 | +574.07% |
| August, 2026 | $4.7278 | $3.0363 | $4.9906 | +515.83% |
| September, 2026 | $3.9864 | $3.6064 | $5.865 | +419.27% |
| October, 2026 | $3.6693 | $2.8493 | $4.1236 | +377.97% |
| November, 2026 | $6.8023 | $3.6451 | $6.9265 | +786.06% |
| December, 2026 | $7.1209 | $5.5752 | $9.2609 | +827.57% |
Coherus Oncology Inc Stock (CHRS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Coherus Oncology Inc (CHRS) is $5.3827, with a high forecast of $10.74 and a low forecast of $0.0287. This indicates an +601.15% increase from the last price of $0.7677.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.0538 | $6.8724 | $9.2724 | +949.09% |
| February, 2027 | $9.9268 | $7.3296 | $10.74 | +1,193% |
| March, 2027 | $8.1154 | $7.9504 | $10.46 | +957.11% |
| April, 2027 | $5.7284 | $5.2284 | $9.6569 | +646.17% |
| May, 2027 | $4.3313 | $3.0498 | $5.9441 | +464.19% |
| June, 2027 | $4.0899 | $2.6785 | $5.6027 | +432.75% |
| July, 2027 | $5.3329 | $3.5657 | $5.8829 | +594.65% |
| August, 2027 | $2.2158 | $2.1758 | $5.8993 | +188.63% |
| September, 2027 | $0.3744 | $0.0287 | $2.5973 | -51.22% |
| October, 2027 | $0.6826 | $0.0602 | $0.9016 | -11.08% |
| November, 2027 | $2.4003 | $0.2088 | $2.5903 | +212.66% |
| December, 2027 | $7.189 | $0.3175 | $7.359 | +836.43% |
Coherus Oncology Inc Stock (CHRS) Price Forecast for 2028
In 2028, Coherus Oncology Inc (CHRS) is projected to reach an average price of $3.8231, with a high projection of $7.5847 and a low estimate of $0.0615. This indicates an +397.99% rise from the last price of $0.7677.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.8119 | $3.7119 | $7.5847 | +396.53% |
| February, 2028 | $3.4048 | $2.6441 | $4.6676 | +343.51% |
| March, 2028 | $2.7235 | $1.9363 | $3.9205 | +254.76% |
| April, 2028 | $0.7864 | $0.6264 | $3.0592 | +2.43% |
| May, 2028 | $0.885 | $0.565 | $2.325 | +15.28% |
| June, 2028 | $3.638 | $0.0615 | $5.5629 | +373.88% |
| July, 2028 | $2.4809 | $2.3009 | $4.0537 | +223.16% |
| August, 2028 | $1.0995 | $0.7395 | $3.0666 | +43.23% |
| September, 2028 | $2.8725 | $0.931 | $3.0325 | +274.17% |
| October, 2028 | $2.7754 | $2.4397 | $3.9539 | +261.52% |
| November, 2028 | $0.0741 | $0.1231 | $3.6611 | -90.35% |
| December, 2028 | $0.077 | $0.2198 | $1.3455 | -89.97% |
Coherus Oncology Inc Stock (CHRS) Price Forecast for 2029
The 2029 price forecast for Coherus Oncology Inc Stock (CHRS) is $6.1378 on average, with a high prediction of $12.27 and a low estimate of $0.0055. This represents an +699.50% increase from the previous price of $0.7677.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8556 | $0.0142 | $1.1934 | +11.45% |
| February, 2029 | $0.9186 | $0.3314 | $1.3314 | +19.65% |
| March, 2029 | $1.3215 | $0.9743 | $1.775 | +72.14% |
| April, 2029 | $0.3944 | $0.1244 | $1.3572 | -48.62% |
| May, 2029 | $1.5969 | $0.0827 | $0.6101 | +108.01% |
| June, 2029 | $0.704 | $0.984 | $0.9912 | -8.30% |
| July, 2029 | $0.5089 | $0.7811 | $0.6668 | -33.71% |
| August, 2029 | $0.4424 | $0.0353 | $0.9247 | -42.37% |
| September, 2029 | $0.1705 | $0.0055 | $0.4148 | -77.79% |
| October, 2029 | $0.1492 | $0.0458 | $0.4592 | -80.57% |
| November, 2029 | $0.0721 | $0.0479 | $0.5664 | -90.61% |
| December, 2029 | $13.20 | $0.0422 | $12.27 | +1,619% |
Coherus Oncology Inc Stock (CHRS) Price Forecast for 2030
Coherus Oncology Inc Stock (CHRS) is expected to reach an average price of $8.5983 in 2030, with a high forecast of $12.16 and a low forecast of $5.0342. This signifies an +1,020% surge from the last price of $0.7677.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.31 | $11.30 | $11.96 | +1,374% |
| February, 2030 | $10.46 | $8.3133 | $8.0712 | +1,262% |
| March, 2030 | $9.361 | $12.09 | $12.16 | +1,119% |
| April, 2030 | $6.7551 | $7.5758 | $9.3881 | +779.92% |
| May, 2030 | $8.2278 | $8.3193 | $8.2522 | +971.75% |
| June, 2030 | $11.26 | $9.4764 | $8.6734 | +1,366% |
| July, 2030 | $8.8747 | $9.2247 | $10.07 | +1,056% |
| August, 2030 | $8.9788 | $9.9088 | $8.6903 | +1,070% |
| September, 2030 | $9.133 | $9.1973 | $8.8659 | +1,090% |
| October, 2030 | $4.7756 | $5.1756 | $7.3786 | +522.07% |
| November, 2030 | $11.85 | $5.0342 | $7.2098 | +1,444% |
| December, 2030 | $11.60 | $10.18 | $11.74 | +1,412% |
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):